ALQELA Trademark

Trademark Overview

On Thursday, April 28, 2022, a trademark application was filed for ALQELA with the United States Patent and Trademark Office. The USPTO has given the ALQELA trademark a serial number of 97386810. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 23, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The ALQELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat the vasomotor symptoms associated with menopause, vulvar and vaginal atrophy and for the prevention of osteoporosis

General Information

Serial Number97386810
Word MarkALQELA
Filing DateThursday, April 28, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations to treat the vasomotor symptoms associated with menopause, vulvar and vaginal atrophy and for the prevention of osteoporosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Monday, May 2, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 7, 2023ASSIGNED TO EXAMINER
Wednesday, February 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 9, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 9, 2023SOU EXTENSION 1 FILED
Thursday, November 9, 2023SOU EXTENSION 1 GRANTED
Saturday, November 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 26, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 26, 2024SOU EXTENSION 2 GRANTED
Friday, April 26, 2024SOU EXTENSION 2 FILED
Saturday, April 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 23, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 23, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

alqela vaginal vulvar atrophy prevention osteoporosis menopause associated preparations treat vasomotor